Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
AssigneeThomas Jefferson University
InventorsScott A. Waldman, Jason Park, Stephanie Schulz
Life of this patent
Estimating the term…
Abstract
Screening and diagnostic reagents, kits and methods for primary and or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing primary and/or metastatic stomach for esophageal cancer are disclosed.
Claims22
1-29. (canceled)
A method of treating an individual suspected of suffering from primary and/or metastatic stomach or esophageal cancer comprising the steps of administering to said individual a therapeutically effective amount of a composition comprising:
- an antibody which a) binds to the protein encoded by SEQ ID NO:1, and b) is conjugated to therapeutic agent selected from the group consisting of:
- chemotherapeutics, radiotherapeutic agents and toxins.
31-34. (canceled)
A method of treating an individual suspected of suffering from primary and/or metastatic stomach or esophageal cancer comprising the steps of administering to said individual a therapeutically effective amount of a composition comprising:
- an antibody which a) binds to the protein encoded by SEQ ID NO:1, and b) is conjugated to therapeutic agent selected from the group consisting of:
- compounds that cause cell death, compounds that inhibit cell division, and compounds that induce cell differentiation.
Dependencies are inferred from the claim text.